Literature DB >> 11686665

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

A Liguori1, P Abete, J M Hayden, F Cacciatore, F Rengo, G Ambrosio, D Bonaduce, M Condorelli, P D Reaven, C Napoli.   

Abstract

BACKGROUND: Although individuals with diabetes mellitus frequently have dyslipidaemias and high blood pressure, much of the increased risk for coronary heart disease is not explained by these and other classical risk factors. Thus, other less widely recognized risk factors, including increased susceptibility of low-density lipoprotein (LDL) to oxidation, might enhance vascular dysfunction and atherogenesis in diabetes. AIMS: We compared both the rate and extent of LDL oxidation ex vivo between 78 poorly controlled individuals with type 1 diabetes and 78 age- and sex-matched non-diabetic controls. We then initiated intensive insulin therapy for 3 months to determine the impact of improved glucose control on LDL composition and oxidation.
RESULTS: Diabetic and non-diabetic individuals did not have significantly different body weights, dietary intake, blood pressure, renal function or plasma lipid levels. LDL composition was also similar in both groups. In contrast, vitamin E content in LDL was significantly lower in diabetic patients. Measures of LDL lipid oxidation, including conjugated diene, lipid peroxide and thiobarbituric acid reactive substances formation, as well as measures of LDL protein modification, were significantly greater in diabetic patients. Levels of hyperglycaemia correlated strongly with each measure of LDL lipid oxidation (r ranges from 0.60-0.81, P<0.05 for each correlation). After improved glucose control (average reduction in % Hb(Alc)of 5.5 units) all measures of LDL oxidation improved dramatically and approached values for non-diabetics. Absolute values of LDL oxidation increased among all categories of age in both diabetic and control individuals, and this relationship persisted even after adjustment for differences in glucose concentrations.
CONCLUSIONS: We demonstrate that hyperglycaemia has a potent but reversible effect on LDL oxidation and that age may independently enhance LDL susceptibility to oxidation. These pathophysiological effects may play an important role in determining vascular complications and atherogenesis in poorly controlled type 1 diabetic patients. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686665     DOI: 10.1053/euhj.2001.2655

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Metabolomics and atherosclerosis.

Authors:  Sascha N Goonewardena; Lisa E Prevette; Ankit A Desai
Journal:  Curr Atheroscler Rep       Date:  2010-07       Impact factor: 5.113

Review 2.  Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.

Authors:  Xilin Yang; Heung M Lee; Juliana C N Chan
Journal:  Nat Rev Endocrinol       Date:  2015-03-24       Impact factor: 43.330

3.  Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Authors:  Xilin Yang; Gary T C Ko; Wing Yee So; Ronald C W Ma; Linda W L Yu; Alice P S Kong; Hailu Zhao; Chun-Chung Chow; Peter C Y Tong; Juliana C N Chan
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

4.  Association of postprandial hyperglycemia with in vitro LDL oxidation in non-smoking patients with type 1 diabetes--a cross-sectional study.

Authors:  Simone H de Castro; Hugo C Castro-Faria-Neto; Marilia B Gomes
Journal:  Rev Diabet Stud       Date:  2005-11-10

5.  Glucose-oxidized low-density lipoproteins enhance insulin-like growth factor I-stimulated smooth muscle cell proliferation by inhibiting integrin-associated protein cleavage.

Authors:  Lee B Allen; Byron E Capps; Emily C Miller; David R Clemmons; Laura A Maile
Journal:  Endocrinology       Date:  2008-10-30       Impact factor: 4.736

6.  The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia.

Authors:  Mark E Pepin; Concetta Schiano; Marco Miceli; Giuditta Benincasa; Gelsomina Mansueto; Vincenzo Grimaldi; Andrea Soricelli; Adam R Wende; Claudio Napoli
Journal:  Exp Cell Res       Date:  2021-01-27       Impact factor: 3.905

7.  Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study.

Authors:  Maoxiang Zhao; Lulu Song; Lan Sun; Miao Wang; Chi Wang; Siyu Yao; Yao Li; Cuijuan Yun; Sijin Zhang; Yizhen Sun; Ziwei Hou; Shouling Wu; Hao Xue
Journal:  Diabetes Care       Date:  2021-06-01       Impact factor: 17.152

8.  Hyperglycemia and blood pressure treatment goal: a cross sectional survey of 18350 patients with type 2 diabetes in 77 tertiary hospitals in China.

Authors:  Linong Ji; Xinyue Zhi; Juming Lu; Xiaohui Guo; Wenying Yang; Weiping Jia; Dajin Zou; Zhiguang Zhou; Qiuhe Ji; Dalong Zhu; Lixin Shi; Jianping Weng
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

9.  Effect of dietary n - 3 polyunsaturated fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats.

Authors:  B Guermouche; N A Soulimane-Mokhtari; S Bouanane; H Merzouk; S Merzouk; M Narce
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

10.  Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control.

Authors:  Maria Rosaria De Pascale; Giuseppe Bruzzese; Ettore Crimi; Vincenzo Grimaldi; Antonio Liguori; Sergio Brongo; Michelangela Barbieri; Antonietta Picascia; Concetta Schiano; Linda Sommese; Nicola Ferrara; Giuseppe Paolisso; Claudio Napoli
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.